LV
Lightstone Ventures
Venture CapitalActiveLightstone Ventures is a leading global venture capital firm.
37
Investments
6
Exits
$375M
AUM
16.2%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Lightstone Ventures.
Investment Thesis & Strategy
Lightstone Ventures invests in various stages of biotech and healthcare companies, seeking to back global leaders in the space.
Investment Activity
Deals per year over the last 10 years
1
20102
20110
20123
20131
20141
20153
20160
20170
20181
2019Portfolio Companies
Selected investments from their portfolio of 37 companies
V
Verve Therapeutics
Biotech · Series A, 2019
O
Obsidian Therapeutics
Biotech · Series A, 2016
S
Silverback Therapeutics
Biotech · Series A, 2016
O
Outset Medical
Healthcare · Series B, 2016
E
Eargo
Healthcare · Series B, 2015
L
Livongo
Healthcare · Series B, 2014
A
Aimmune Therapeutics
Biotech · Series B, 2013
C
Calico
Biotech · Growth, 2013
C
Cartiva
Healthcare · Series C+, 2013
V
Vaxart
Biotech · Series A, 2011
V
Vascular Dynamics
Healthcare · Series A, 2011
P
Proteus Digital Health
Healthcare · Series C+, 2010
Frequently Asked Questions
Lightstone Ventures focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Threshold
Menlo Park, United States · 841 deals
Lightspeed Venture Partners
Menlo Park, United States · 839 deals
Andreessen Horowitz
Menlo Park, United States · 826 deals
Khosla Ventures
Menlo Park, United States · 769 deals
Greylock
Menlo Park, United States · 720 deals
GGV Capital
Menlo Park, United States · 625 deals